These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

300 related items for PubMed ID: 11697832

  • 1. Clinical-benefit response in advanced non-small-cell lung cancer: A multicentre prospective randomised phase III study of single agent gemcitabine versus cisplatin-vindesine.
    Vansteenkiste JF, Vandebroek JE, Nackaerts KL, Weynants P, Valcke YJ, Verresen DA, Devogelaere RC, Marien SA, Humblet YP, Dams NL, Leuven Lung Cancer Group.
    Ann Oncol; 2001 Sep; 12(9):1221-30. PubMed ID: 11697832
    [Abstract] [Full Text] [Related]

  • 2. Influence of cisplatin-use, age, performance status and duration of chemotherapy on symptom control in advanced non-small cell lung cancer: detailed symptom analysis of a randomised study comparing cisplatin-vindesine to gemcitabine.
    Vansteenkiste J, Vandebroek J, Nackaerts K, Dooms C, Galdermans D, Bosquée L, Delobbe A, Deschepper K, Van Kerckhoven W, Vandeurzen K, Deman R, D'Odemont JP, Siemons L, Van den Brande P, Dams N, Leuven Lung Cancer Group.
    Lung Cancer; 2003 May; 40(2):191-9. PubMed ID: 12711121
    [Abstract] [Full Text] [Related]

  • 3. Cisplatin, gemcitabine, and vinorelbine combination therapy in advanced non-small-cell lung cancer: a phase II randomized study of the Southern Italy Cooperative Oncology Group.
    Comella P, Frasci G, Panza N, Manzione L, Lorusso V, Di Rienzo G, Cioffi R, De Cataldis G, Maiorino L, Bilancia D, Nicolella G, Natale M, Carpagnano F, Pacilio C, De Lena M, Bianco A, Comella G.
    J Clin Oncol; 1999 May; 17(5):1526-34. PubMed ID: 10334540
    [Abstract] [Full Text] [Related]

  • 4. The use of gemcitabine in non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group. Provincial Systemic Treatment Disease Site Group.
    Evans WK, Kocha W, Gagliardi A, Eady A, Newman TE.
    Cancer Prev Control; 1999 Feb; 3(1):84-94. PubMed ID: 10474757
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Gemcitabine (GEM) and carboplatin (CBDCA) versus cisplatin (CDDP) and vinblastine (VLB) in advanced non-small-cell lung cancer (NSCLC) stages III and IV: a phase III randomised trial.
    Grigorescu AC, Draghici IN, Nitipir C, Gutulescu N, Corlan E.
    Lung Cancer; 2002 Jul; 37(1):9-14. PubMed ID: 12057861
    [Abstract] [Full Text] [Related]

  • 8. Single-agent gemcitabine: an active and better tolerated alternative to standard cisplatin-based chemotherapy in locally advanced or metastatic non-small cell lung cancer.
    ten Bokkel Huinink WW, Bergman B, Chemaissani A, Dornoff W, Drings P, Kellokumpu-Lehtinen PL, Liippo K, Mattson K, von Pawel J, Ricci S, Sederholm C, Stahel RA, Wagenius G, Walree NV, Manegold C.
    Lung Cancer; 1999 Nov; 26(2):85-94. PubMed ID: 10568679
    [Abstract] [Full Text] [Related]

  • 9. Gemcitabine plus cisplatin vs. gemcitabine plus carboplatin in stage IIIb and IV non-small cell lung cancer: a phase III randomized trial.
    Zatloukal P, Petruzelka L, Zemanová M, Kolek V, Skricková J, Pesek M, Fojtů H, Grygárková I, Sixtová D, Roubec J, Horenková E, Havel L, Průsa P, Nováková L, Skácel T, Kůta M.
    Lung Cancer; 2003 Sep; 41(3):321-31. PubMed ID: 12928123
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Cisplatin plus gemcitabine versus a cisplatin-based triplet versus nonplatinum sequential doublets in advanced non-small-cell lung cancer: a Spanish Lung Cancer Group phase III randomized trial.
    Alberola V, Camps C, Provencio M, Isla D, Rosell R, Vadell C, Bover I, Ruiz-Casado A, Azagra P, Jiménez U, González-Larriba JL, Diz P, Cardenal F, Artal A, Carrato A, Morales S, Sanchez JJ, de las Peñas R, Felip E, López-Vivanco G, Spanish Lung Cancer Group.
    J Clin Oncol; 2003 Sep 01; 21(17):3207-13. PubMed ID: 12947054
    [Abstract] [Full Text] [Related]

  • 12. Gemcitabine alone or with cisplatin for the treatment of patients with locally advanced and/or metastatic pancreatic carcinoma: a prospective, randomized phase III study of the Gruppo Oncologia dell'Italia Meridionale.
    Colucci G, Giuliani F, Gebbia V, Biglietto M, Rabitti P, Uomo G, Cigolari S, Testa A, Maiello E, Lopez M.
    Cancer; 2002 Feb 15; 94(4):902-10. PubMed ID: 11920457
    [Abstract] [Full Text] [Related]

  • 13. Gemcitabine (GEM) and vindesine (VDS) in advanced non-small cell lung cancer (NSCLC): a phase II study in elderly or poor performance status patients.
    Santo A, Genestreti G, Terzi A, Azzoni P, Sava T, Manno P, Molino A, Pattaro C, Micciolo R, Cetto GL.
    Lung Cancer; 2006 Sep 15; 53(3):355-60. PubMed ID: 16837100
    [Abstract] [Full Text] [Related]

  • 14. Factorial phase III randomised trial of rofecoxib and prolonged constant infusion of gemcitabine in advanced non-small-cell lung cancer: the GEmcitabine-COxib in NSCLC (GECO) study.
    Gridelli C, Gallo C, Ceribelli A, Gebbia V, Gamucci T, Ciardiello F, Carozza F, Favaretto A, Daniele B, Galetta D, Barbera S, Rosetti F, Rossi A, Maione P, Cognetti F, Testa A, Di Maio M, Morabito A, Perrone F, GECO investigators.
    Lancet Oncol; 2007 Jun 15; 8(6):500-12. PubMed ID: 17513173
    [Abstract] [Full Text] [Related]

  • 15. Second-line chemotherapy with paclitaxel, cisplatin and gemcitabine in pre-treated sensitive cisplatin-based patients with advanced non-small cell lung cancer.
    Rosati G, Rossi A, Nicolella G, Panza N.
    Anticancer Res; 2000 Jun 15; 20(3B):2229-33. PubMed ID: 10928183
    [Abstract] [Full Text] [Related]

  • 16. Cisplatin, gemcitabine and vinorelbine in locally advanced or metastatic non-small-cell lung cancer: a phase I study.
    Frasci G, Panza N, Comella P, Nicolella GP, Natale M, Pacilio C, Gravina A, Caputi V, Botti G, Comella G.
    Ann Oncol; 1997 Oct 15; 8(10):1045-8. PubMed ID: 9402180
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Weekly gemcitabine and monthly cisplatin for advanced non-small cell lung carcinoma.
    Abratt RP, Hacking DJ, Goedhals L, Bezwoda WR.
    Semin Oncol; 1997 Jun 15; 24(3 Suppl 8):S8-18-S8-23. PubMed ID: 9207311
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A randomized study comparing two different schedules of administration of cisplatin in combination with gemcitabine in advanced nonsmall cell lung carcinoma.
    Ricci S, Antonuzzo A, Galli L, Tibaldi C, Bertuccelli M, Lopes Pegna A, Petruzzelli S, Bonifazi V, Orlandini C, Franco Conte P.
    Cancer; 2000 Oct 15; 89(8):1714-9. PubMed ID: 11042565
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.